MCL
Rituximab After Auto-HCT Prolongs Survival in MCL
San Diego—In younger patients with mantle cell lymphoma (MCL) who have received an autologous hematopoietic ...
APRIL 15, 2017
Chemotherapy-Free Induction Possible With Ibrutinib-Rituximab
Patients with mantle cell lymphoma may be able to undergo induction treatment with a combination of ibrutinib and ...
JANUARY 5, 2017
Load more